117 related articles for article (PubMed ID: 15803470)
1. High-yield retroviral production using a temperature-modulated two-stage operation.
Kwon YJ; Peng CA
Biotechnol Bioeng; 2005 May; 90(3):365-72. PubMed ID: 15803470
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of retroviral production systems using quantitative analysis.
Kwon YJ; Peng CA
Biotechnol Prog; 2003; 19(2):528-37. PubMed ID: 12675597
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
4. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
Pan D; Whitley CB
J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
[TBL] [Abstract][Full Text] [Related]
5. Effects of culture parameters on the production of retroviral vectors by a human packaging cell line.
McTaggart S; Al-Rubeai M
Biotechnol Prog; 2000; 16(5):859-65. PubMed ID: 11027182
[TBL] [Abstract][Full Text] [Related]
6. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
7. Optimized conditions for the production of recombinant amphotropic retroviral vector preparations.
Kaptein LC; Greijer AE; Valerio D; van Beusechem VW
Gene Ther; 1997 Feb; 4(2):172-6. PubMed ID: 9081708
[TBL] [Abstract][Full Text] [Related]
8. Modeling retrovirus production for gene therapy. 1. Determination Of optimal bioreaction mode and harvest strategy.
Cruz PE; Almeida JS; Murphy PN; Moreira JL; Carrondo MJ
Biotechnol Prog; 2000; 16(2):213-21. PubMed ID: 10753446
[TBL] [Abstract][Full Text] [Related]
9. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
Nehring D; Gonzalez R; Pörtner R; Czermak P
J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
[TBL] [Abstract][Full Text] [Related]
10. Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18.
Gerin PA; Searle PF; Al-Rubeai M
Biotechnol Prog; 1999; 15(5):941-8. PubMed ID: 10514266
[TBL] [Abstract][Full Text] [Related]
11. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
12. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of retrovirus production and decay.
Le Doux JM; Davis HE; Morgan JR; Yarmush ML
Biotechnol Bioeng; 1999 Jun; 63(6):654-62. PubMed ID: 10397822
[TBL] [Abstract][Full Text] [Related]
14. State-of-the-art of the production of retroviral vectors.
Merten OW
J Gene Med; 2004 Feb; 6 Suppl 1():S105-24. PubMed ID: 14978755
[TBL] [Abstract][Full Text] [Related]
15. PH, pCO2, and temperature effect on R-adenovirus production.
Jardon M; Garnier A
Biotechnol Prog; 2003; 19(1):202-8. PubMed ID: 12573026
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vector production under serum deprivation: The role of lipids.
Rodrigues AF; Carmo M; Alves PM; Coroadinha AS
Biotechnol Bioeng; 2009 Dec; 104(6):1171-81. PubMed ID: 19655394
[TBL] [Abstract][Full Text] [Related]
17. Effect of medium sugar source on the production of retroviral vectors for gene therapy.
Coroadinha AS; Ribeiro J; Roldão A; Cruz PE; Alves PM; Merten OW; Carrondo MJ
Biotechnol Bioeng; 2006 May; 94(1):24-36. PubMed ID: 16514678
[TBL] [Abstract][Full Text] [Related]
18. Application of a mathematical model and Differential Evolution algorithm approach to optimization of bacteriocin production by Lactococcus lactis C7.
Moonchai S; Madlhoo W; Jariyachavalit K; Shimizu H; Shioya S; Chauvatcharin S
Bioprocess Biosyst Eng; 2005 Nov; 28(1):15-26. PubMed ID: 16047169
[TBL] [Abstract][Full Text] [Related]
19. High rate treatment of terephthalic acid production wastewater in a two-stage anaerobic bioreactor.
Kleerebezem R; Beckers J; Hulshoff Pol LW; Lettinga G
Biotechnol Bioeng; 2005 Jul; 91(2):169-79. PubMed ID: 15889396
[TBL] [Abstract][Full Text] [Related]
20. Fed-batch bioreactor process scale-up from 3-L to 2,500-L scale for monoclonal antibody production from cell culture.
Yang JD; Lu C; Stasny B; Henley J; Guinto W; Gonzalez C; Gleason J; Fung M; Collopy B; Benjamino M; Gangi J; Hanson M; Ille E
Biotechnol Bioeng; 2007 Sep; 98(1):141-54. PubMed ID: 17657776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
